中国组织工程研究 ›› 2011, Vol. 15 ›› Issue (51): 9523-9526.doi: 10.3969/j.issn.1673-8225.2011.51.006

• 细胞外基质材料 extracellular matrix materials • 上一篇    下一篇

凝胶型E基质在大鼠脊柱后外侧融合中的应用

吴贵忠,杨惠林,孙智勇,陈康武,顾  勇   

  1. 苏州大学附属第一医院骨科,江苏省苏州市  215006
  • 收稿日期:2011-09-29 修回日期:2011-10-31 出版日期:2011-12-17 发布日期:2011-12-17
  • 通讯作者: 杨惠林,博士,主任医师,博士生导师,苏州大学附属第一医院骨科,江苏省苏州市 215006 soochowspine@139.com
  • 作者简介:吴贵忠,男,1981年生,江苏省吴江市人,汉族,2009年苏州大学毕业毕业,硕士,医师,主要从事脊柱的基础与临床方面的研究。 suzhouwuguizhong@163.com

Application of glue-like E-matrix in posterolateral spinal fusion of rats

Wu Gui-zhong, Yang Hui-lin, Sun Zhi-yong, Chen Kang-wu, Gu Yong   

  1. Department of Orthopedics, the First Affiliated Hospital of Soochow University, Suzhou  215006, Jiangsu Province, China
  • Received:2011-09-29 Revised:2011-10-31 Online:2011-12-17 Published:2011-12-17
  • Contact: Yang Hui-lin, Doctor, Chief physician, Doctoral supervisor, Department of Orthopedics, the First Affiliated Hospital of Soochow University, Suzhou 215006, Jiangsu Province, China soochowspine@ 139.com
  • About author:Wu Gui-zhong★, Master, Physician, Department of Orthopedics, the First Affiliated Hospital of Soochow University, Suzhou 215006, Jiangsu Province, China suzhouwuguizhong@163.com

摘要:

背景:重组人骨形态发生蛋白(recombinant human bone morphogenetic protein,rhBMP)的骨诱导能力已在各种动物模型和临床试验中得到验证。
目的:利用大鼠脊柱后外侧融合模型,分析凝胶型E基质作为rhBMP-2的新型载体在脊柱后外侧融合中的作用。
方法:建立大鼠后外侧融合模型,105只Lewis雄性大鼠在相同条件下分别在L4-5横突间植入可吸收明胶海绵复合不同质量的rhBMP-2,对加或不加凝胶型E基质进行分组观察。
结果及结论:10 μg和3 μg rhBMP-2两组融合率100%,1,0.5,0.1 μg rhBMP-2组的融合率分别是40%,10%,0%。加E基质的0.5 μg以上的rhBMP-2组全部融合,而0.1,0.05 μg rhBMP-2组未发现融合迹象。Micro-CT扫描提示3 μg rhBMP-2复合明胶海绵加E基质与10 μg rhBMP-2复合明胶海绵组融合节段形成的新生骨骨量相似,而0.1,0.05 μg rhBMP-2不管有无E基质,都无新骨形成。说明应用E基质作为载体能明显提高rhBMP-2在脊柱后外侧的融合成功率,但当rhBMP-2的剂量过小时,使用E基质做载体也不能达到预期的脊柱融合。

关键词: 凝胶型E基质, 重组人骨形态发生蛋白, rhBMP-2, 脊柱后外侧融合模型, 新生骨

Abstract:

BACKGROUND: Various animal models and clinical trials show that the recombinant human bone morphogenetic protein (rhBMP) has the capacity of bone induction.
OBJECTIVE: To study the effect of glue-like E-matrix as a new type of carrier for rhBMP-2 on posterolateral spinal fusion of rats.
METHODS: Posterolateral fusion models were established in 105 male Lewis rats. Absorbable gelatin sponge and rhBMP-2 with different qualities were implanted into the L4-5 intertransverse of rats under the same conditions. Observation of adding glue-like E-matrix or not into groups was performed.
RESULTS AND CONCLUSIONS: Fusion rates of the rats with 10 μg rhBMP-2 and 3 μg rhBMP-2 were 100%, and those of the rats with 1 μg, 0.5 μg and 0.1 μg of rhBMP-2 were 40%, 10% and 0% respectively. In the adding glue-like E-matrix groups, the fusion rate of rats with > 0.5 μg rhBMP-2 was 100%, but no fusion was observed in the rats with 0.1 μg and 0.05 μg rhBMP-2. The micro-CT results revealed that the amount of the new bone created in the 10 μg rhBMP-2 + E-matrix group and the 3 μg rhBMP-2+E-matrix group were similar. However, there was no new bone created in the 0.1 μg and 0.05 μg rhBMP-2 groups containing E-matrix or not. E-matrix can enhance the fusion rate of rhBMP-2 significantly in posterolateral spinal fusion. However, the expected fusion cannot be achieved by E-matrix if the dose of rhBMP-2 is too small.

中图分类号: